Better clinical outcomes for all women.

It starts simply with If and Why?

If we know there are sex-based differences at the genetic, cellular, biochemical and physiological levels, then why doesn’t more medical research start from the women’s perspective? 

Femtech is an underserved industry attracting only ten percent of investment funding while working for fifty percent of the world’s population. 

Yet we absolutely know there is a range of areas where AI can have a profound impact on women’s health outcomes. These include Ovarian, Breast, and Cervical Cancers, Endometriosis, and Polycystic Ovarian Syndrome to name a few.

Uniquely, our clinic-centric model means we work collaboratively with and for clinics globally. Sourcing globally diverse data, we remove the bias associated with individual clinics, whether it is related to patient demographics or clinical setting. And our AI, which is built on this data, can be generalized to other clinics. 

Importantly – and again, uniquely – this means the healthcare products we develop are globally scalable. They benefit all patients, and they deliver commercial value to contributing clinics.

Which brings us neatly to our reason for being as an AI specialist tech company.

If we can apply AI to medical research and practice, and work collaboratively with those at the coalface to markedly advance women’s medicine, then why not make all these gains?

Our Founders

Executive Team

Our Founders